Filing Details
- Accession Number:
- 0001127602-17-010311
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-03 18:22:29
- Reporting Period:
- 2017-03-02
- Filing Date:
- 2017-03-03
- Accepted Time:
- 2017-03-03 18:22:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1331852 | S Joseph Zakrzewski | C/O Insulet Corporation 600 Technology Park Drive, Suite 200 Billerica MA 01821 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-02 | 9,520 | $18.75 | 37,369 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-02 | 18,480 | $7.06 | 55,849 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-02 | 4,000 | $14.48 | 59,849 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-02 | 4,000 | $20.90 | 63,849 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-03-02 | 4,000 | $17.75 | 67,849 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-02 | 4,000 | $48.03 | 63,849 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-03-02 | 13,721 | $46.31 | 50,128 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-03-02 | 22,279 | $46.99 | 27,849 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-02 | 9,520 | $0.00 | 9,520 | $18.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-02 | 18,480 | $0.00 | 18,480 | $7.06 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-02 | 4,000 | $0.00 | 4,000 | $14.48 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-02 | 4,000 | $0.00 | 4,000 | $20.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-02 | 4,000 | $0.00 | 4,000 | $17.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-05-08 | No | 4 | M | Direct | |
| 0 | 2019-07-30 | No | 4 | M | Direct | |
| 0 | 2020-06-01 | No | 4 | M | Direct | |
| 0 | 2021-05-12 | No | 4 | M | Direct | |
| 0 | 2022-06-01 | No | 4 | M | Direct |
Footnotes
- Includes 3,810 restricted stock units granted on May 11, 2016, which vest on April 30, 2017; 1,000 restricted stock units granted on June 2, 2014, which vest on April 30, 2017; and 2,020 restricted stock units granted on May 13, 2015, which vest 50% of the total units on April 30, 2017 and 50% of the total units on April 30, 2018, subject to continued service as a director or consultant. Vested shares will be delivered to the reporting person as soon as practiable following a vesting date.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $45.65 to $46.645. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $46.66 to $47.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option is subject to a three-year vesting period with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant.
- This option shall vest as to 100% of the total award on April 30, 2017, subject to continued service as a director or consultant.
- This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2013, 25% of the total award vesting on April 30, 2014 and 25% of the total award vesting on April 30, 2015, subject to continued service as a director or consultant.
Billionaire Hedge Funds
